Navigation Links
Cyberonics to Present at Maxim Group Growth Conference
Date:9/17/2009

HOUSTON, Sept. 17 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that James Reinstein, Cyberonics' Vice President, Sales & Marketing and General Manager, International, will present at the Maxim Group Growth Conference in New York on Tuesday, September 29, 2009 at 2:30 PM EDT. Maxim will host a webcast of the presentation live and by replay at http://www.wsw.com/webcast/maxim2/cybx/. The replay will be available for 90 days following the conference. Presentation slides will be available on-line at www.cyberonics.com by 8:00 AM EDT on Tuesday, September 29, 2009. The presentation can also be accessed at www.cyberonics.com by clicking on the link for this webcast. Access to the webcast is not password protected.

About Cyberonics, Inc. and VNS Therapy(TM)

Cyberonics, Inc. (Nasdaq: CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the treatments of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics, Inc. and VNS Therapy(TM) is available at www.cyberonics.com and www.vnstherapy.com.

    CONTACT INFORMATION:
    Greg Browne, CFO
    Cyberonics, Inc.
    100 Cyberonics Blvd.
    Houston, TX 77058
    Main:  (281) 228-7262
    Fax:  (281) 218-9332
    ir@cyberonics.com


'/>"/>
SOURCE Cyberonics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cyberonics to Present at UBS Global Life Sciences Conference
2. Cyberonics Reports Strong Fiscal 2010 First Quarter Results
3. Cyberonics to Present at Canaccord Adams 29th Annual Global Growth Conference
4. Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 First Quarter Financial Results
5. Cyberonics Announces Exclusive Distribution Agreement With Nihon Kohden in Japan
6. Cyberonics Names Bryan D. Olin, Ph.D. Vice President, Quality
7. Cyberonics Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2009 Financial Results
8. Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter
9. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 Third Quarter Financial Results
10. Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development
11. Cyberonics to Present at Piper Jaffray 20th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... N.Y (PRWEB) , ... October 13, 2017 , ... Lori ... became a member of ElderCounsel, a national organization of elder law and special needs ... changing laws and rules. It also provides a forum to network with elder law ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 ... mobile health and big data solutions, today announced that its MyDario product ... check your local TV listings for when The Dr. Oz Show airs ... The ... this month. ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
Breaking Medicine Technology: